Home › Melanoma › Oklahoma › Oklahoma City
Pag-aaral pangklinika para sa Melanoma sa Oklahoma City, OK
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Oklahoma City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Mercy Hospital Oklahoma City, Oklahoma City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Nagre-recruitPhase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- University of Oklahoma Health Sciences Center, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Nagre-recruitObservasyonal na pag-aaral
- Mercy Hospital - OKC, Oklahoma City
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- Retina Consultants of Oklahoma, Oklahoma City
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Mercy Hospital Oklahoma City, Oklahoma City
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Nagre-recruitPhase 3
- OU Health Stephenson Cancer Center, Oklahoma City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- OUHSC Stephenson Cancer Center, Oklahoma City
- Mercy Health Center - Oncology Hematology, Oklahoma City
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- Durham, NC21 pag-aaral
- Atlanta, GA21 pag-aaral
- Salt Lake City, UT21 pag-aaral
Iba pang pag-aaral sa Oklahoma City
- Non-Small Cell Lung Cancer28 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Colorectal Cancer22 pag-aaral
- Kanser sa Prostate21 pag-aaral
- Kanser sa Baga19 pag-aaral
- Kanser sa Suso17 pag-aaral
- Metastatic Cancer16 pag-aaral
- Kanser (lahat ng uri)14 pag-aaral
- Acute Myeloid Leukemia14 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg13 pag-aaral
- Kanser sa Pantog11 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.